ACP
Acuta Capital Partners’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.9M | Sell |
22,576
-764
| -3% | -$132K | 5.44% | 6 |
|
|
2025
Q1 | $3.64M | Buy |
23,340
+364
| +2% | +$56.7K | 4.22% | 9 |
|
|
2024
Q4 | $3.16M | Buy |
22,976
+1,976
| +9% | +$272K | 3.18% | 12 |
|
|
2024
Q3 | $3.14M | Buy |
+21,000
| New | +$3.14M | 2.54% | 17 |
|
|
2020
Q3 | – | Sell |
-55,500
| Closed | -$8.21M | – | 48 |
|
|
2020
Q2 | $8.21M | Sell |
55,500
-7,700
| -12% | -$1.14M | 2.37% | 16 |
|
|
2020
Q1 | $7.12M | Buy |
63,200
+40,700
| +181% | +$4.58M | 3.45% | 11 |
|
|
2019
Q4 | $3.13M | Buy |
+22,500
| New | +$3.13M | 0.78% | 28 |
|
|
2018
Q4 | – | Sell |
-71,500
| Closed | -$5.07M | – | 20 |
|
|
2018
Q3 | $5.07M | Sell |
71,500
-239,611
| -77% | -$17M | 1.81% | 14 |
|
|
2018
Q2 | $20.7M | Sell |
311,111
-232,889
| -43% | -$15.5M | 3.68% | 8 |
|
|
2018
Q1 | $35.6M | Buy |
544,000
+13,000
| +2% | +$850K | 5.81% | 4 |
|
|
2017
Q4 | $21.3M | Buy |
531,000
+31,000
| +6% | +$1.24M | 4.02% | 5 |
|
|
2017
Q3 | $18.1M | Sell |
500,000
-424,483
| -46% | -$15.4M | 3.25% | 7 |
|
|
2017
Q2 | $25.7M | Buy |
924,483
+374,483
| +68% | +$10.4M | 7.18% | 1 |
|
|
2017
Q1 | $15.4M | Sell |
550,000
-25,309
| -4% | -$709K | 3.65% | 6 |
|
|
2016
Q4 | $11.6M | Buy |
575,309
+212,309
| +58% | +$4.3M | 4.33% | 8 |
|
|
2016
Q3 | $7.3M | Sell |
363,000
-109,800
| -23% | -$2.21M | 2.74% | 9 |
|
|
2016
Q2 | $6.27M | Sell |
472,800
-150,831
| -24% | -$2M | 3.01% | 10 |
|
|
2016
Q1 | $11.6M | Buy |
623,631
+104,388
| +20% | +$1.94M | 6.47% | 6 |
|
|
2015
Q4 | $9.51M | Buy |
519,243
+49,350
| +11% | +$904K | 4.55% | 6 |
|
|
2015
Q3 | $8.32M | Buy |
469,893
+48,042
| +11% | +$850K | 4.81% | 4 |
|
|
2015
Q2 | $7.46M | Buy |
421,851
+193,239
| +85% | +$3.42M | 4.61% | 5 |
|
|
2015
Q1 | $3.97M | Buy |
+228,612
| New | +$3.97M | 3.34% | 7 |
|